The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

David J. Heal(Nexor (United Kingdom)), Sharon L. Smith(Unknown), Sharon C. Cheetham(RenaSci (United Kingdom))

Neuropharmacology

September 16, 2009

10.1016/j.neuropharm.2009.08.020

Cited by 197

Related Papers

Amphetamine, past and present – a pharmacological and clinical perspective

|Journal of Psychopharmacology|2013|614

GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin

|Endocrinology|2006|432

Experimental Approaches to Anxiety and Depression

|Behavioural Pharmacology|1993|363

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology

|Journal of Psychopharmacology|2014|284

The pharmacology of the behavioral and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)

|Psychopharmacology|1987|198